Stock Spotlight Archives - Page 141 of 388

MondayJan 03, 2022 12:29 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) CEO Discusses Key Advantages of the Fan Pass Live Artist Platform

Friendable’s (OTC: FDBL) CEO and Co-Founder Robert Rositano Jr. was recently featured on the Hellblazer Biz Podcast. Rositano joined Chris Gordon, the program’s host, to discuss ventures with his brother, Dean Rositano, where the two have worked together as business partners, for almost 30 years, sharing a passion for the music industry. “In the early 2000s, the brothers worked with a major industry name to produce a new venture/revenue stream for independent artists. Together with the help of Herbie Herbert and his partner Bill Graham and their recording studio, the brothers would record artists and invite friends, family and fans…

ThursdayDec 30, 2021 1:02 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) TRACE Selected as Official Water Supplier of Summer 2022 Highlight Event

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health and wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The company has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, which includes the highly anticipated Formula E electric car race. The three-day Canadian E-Fest is slated to take place between June 30 to July 2, 2022, and will welcome the ABB FIA Formula E…

ThursdayDec 30, 2021 11:50 am

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) Expanding Robust Portfolio of Novel Compounds

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company, has aimed to transform the treatment of mental health disorders and addiction since its inception. The company has already developed first- and second-generation novel therapeutics designed to treat addiction, post-traumatic stress disorder (“PTSD”) and other mental health conditions. “Mydecine recently released its third-quarter 2021 update and a noteworthy announcement for the 2021 calendar year. It offers a glimpse into achievements to date, and what stakeholders can anticipate in the last quarter of the 2021 financial year and for the 2022 calendar year,” reads a recent article. “Most notably, Mydecine…

ThursdayDec 30, 2021 11:38 am

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Core Operations to Center Around Its Rapidly Growing SaaS Platform

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has recently announced that it will no longer have to consolidate the financials of its former subsidiary, BIGtoken Inc. Following the successful spin-off of BIGtoken, SRAX’s core operations will be centered around Sequire, which has grown to over 9 million followers whilst simultaneously seeing its number of subscribers swell to 250 public companies. “Sequire has witnessed the company’s growth trajectory rise from strength to strength, with the company recently announcing the launch of its new IR website builder,…

ThursdayDec 30, 2021 11:02 am

QualityStocksNewsBreaks – Why Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Is ‘One to Watch’

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded, vertically integrated plant-based foods company. Eat Well combines the best of agribusiness, food tech and CPG brands to supply the world with innovative, delicious and better-for-you foods. “The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (‘CPG’),” reads a recent article. “Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts…

WednesdayDec 29, 2021 12:16 pm

QualityStocksNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Bringing Solutions to Empower People to Take Charge of Their Health, Well-Being

Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. Since its founding in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved to create wearable technologies and digital health care solutions that encourage and empower people to take charge of their health and well-being. “The company’s flagship product, sugarBEAT(R), is a wearable, non-invasive and flexible continuous glucose monitor (‘CGM’) designed to help people with diabetes and prediabetes manage…

WednesdayDec 29, 2021 11:56 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR) Continuing Strong Growth in iGaming Space

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA: 7CR), a propriety software-as-a-service “SaaS” technology company delivering mobile live dealer technology to online gaming operators globally, is emerging as a clear leader in the burgeoning iGaming space. Most recently, the company announced that its total player wagering for November 2021 increased approximately 12% compared to October 2021. Further, monthly active player numbers are up 28%, bet spots have increased over 22%, and the company added three new operators to its platform. This brings the total number of operators using Playgon tech to 26, with eight more waiting in the wings at various…

WednesdayDec 29, 2021 11:47 am

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Advancing as Innovator in DTC Hearing Aid Market

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently announced its acquisition of Hearing Assist II LLC (“HearingAssist”). A long established leader in the market, HearingAssist has sold over 500,000 hearing aids since 2008 and has generated upwards of $72 million in top-line revenues since 2018, transforming into Walmart’s largest hearing aid supplier in the process. The acquisition will enable InnerScope to accelerate its revenue and growth strategy, as it consolidates the sales generated by HearingAssist’s hearing product kiosks, which are currently in place across 757 Walmart stores in five states.…

WednesdayDec 29, 2021 11:32 am

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Taking Part in POC Testing Revolution with HealthTab(TM)

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is positioning in an era where point-of-care (“POC”) testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more. In the shift to a more decentralized testing approach, Avricore is taking part in this disruption through its POCT platform, HealthTab(TM), found at select community pharmacies. “HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results,” reads a recent article. “The analyzers screen for more than 20 biomarkers associated with select chronic and infectious diseases and communicate them in real-time with patients and…

TuesdayDec 28, 2021 1:41 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Witnessing Swift Advancement in R&D Pipeline, Overall Business

Cybin (NYSE American: CYBN) (NEO: CYBN), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently released its financial and operating report for Q2 2021, with notable company milestones and achievements highlighted. The company plans to move through the ongoing remaining preclinical studies for its CYB003 novel deuterated psilocybin analog and submit an investigational new drug application and clinical trial application in the second quarter of 2022 in the U.S. and the U.K., respectively. “Other notable company achievements during the quarter include the U.S. Drug Enforcement Agency’s approval of a Schedule I manufacturing license for Cybin’s…

Site Search

Company Search

Category: Stock Spotlight